The maturing yet highly lucrative market for multiple sclerosis (MS) disease-modifying therapies (DMTs) will...
COMING SOON A growing number of clinically unique disease-modifying therapies (DMTs) have been approved for the treatment of relapsing forms of...
The maturing yet highly lucrative market for multiple sclerosis (MS) disease-modifying therapies (DMTs) will c...
MARKET OUTLOOK Multiple Sclerosis (MS), a chronic immune-mediated disease of the nervous system, is classified as a rare disease in China because...
The dynamic multiple sclerosis (MS) market in the United States features more than a dozen high-cost branded (and one generic) disease-modifying...
DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key multiple sclerosis pat...
The shifting multiple sclerosis (MS) therapy market continues to evolve as new disease-modifying therapies (DMT
With more than a dozen disease-modifying therapies (DMTs) available to treat multiple sclerosis (MS), the trea...
With over a dozen immunomodulatory disease-modifying therapies (DMTs) available to treat multiple sclerosis (MS
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
The multiple sclerosis (MS) therapy market comprises more than a dozen disease-modifying therapies (DMTs) sp...
MARKET OUTLOOK Roche/Genentech achieved a clinical and regulatory milestone with the approval of Ocrevus for the treatment of primary-progressive...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
DRG Epidemiology's coverage of multiple sclerosis (MS) comprises epidemiological estimates of key patient...
Get content updates to your inbox
Subscribe